Evaluation of the long‐term cost‐effectiveness of once‐weekly semaglutide versus dulaglutide for treatment of type 2 diabetes mellitus in the UK

AIMS: Glucagon‐like peptide‐1 (GLP‐1) receptor agonists are appealing as glucose‐lowering therapy for individuals with type 2 diabetes mellitus (T2DM) as they also reduce body weight and are associated with low rates of hypoglycaemia. This analysis assessed the long‐term cost‐effectiveness of semagl...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Diabetes Obes Metab
Главные авторы: Viljoen, Adie, Hoxer, Christina S., Johansen, Pierre, Malkin, Samuel, Hunt, Barnaby, Bain, Stephen C.
Формат: Artigo
Язык:Inglês
Опубликовано: Blackwell Publishing Ltd 2018
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6587509/
https://ncbi.nlm.nih.gov/pubmed/30362224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13564
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы